BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15118281)

  • 1. Attitudes of Japanese cardiologists toward anticoagulation for nonvalvular atrial fibrillation and reasons for its underuse.
    Inoue H; Nozawa T; Okumura K; Iwasa A; Lee JD; Shimizu A; Hayano M; Yano K
    Circ J; 2004 May; 68(5):417-21. PubMed ID: 15118281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients.
    Lackner TE; Battis GN
    Arch Fam Med; 1995 Dec; 4(12):1017-26. PubMed ID: 7496550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
    Go AS; Hylek EM; Borowsky LH; Phillips KA; Selby JV; Singer DE
    Ann Intern Med; 1999 Dec; 131(12):927-34. PubMed ID: 10610643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study.
    Cullinane M; Wainwright R; Brown A; Monaghan M; Markus HS
    Stroke; 1998 Sep; 29(9):1810-5. PubMed ID: 9731600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
    Yasaka M; Yamaguchi T
    CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic embolisation in non-valvular atrial fibrillation and its relationship to anticoagulation therapy.
    Tinkler K; Cullinane M; Kaposzta Z; Markus HS
    Eur J Ultrasound; 2002 Jun; 15(1-2):21-7. PubMed ID: 12044849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey.
    Gross CP; Vogel EW; Dhond AJ; Marple CB; Edwards RA; Hauch O; Demers EA; Ezekowitz M
    Clin Ther; 2003 Jun; 25(6):1750-64. PubMed ID: 12860496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
    Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary stroke prevention in nonvalvular atrial fibrillation: implementing the clinical trial findings.
    Howard PA; Duncan PW
    Ann Pharmacother; 1997 Oct; 31(10):1187-96. PubMed ID: 9337445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
    Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
    BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
    Gage BF; Cardinalli AB; Albers GW; Owens DK
    JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: a J-RHYTHM Registry analysis.
    Yamashita T; Inoue H; Okumura K; Atarashi H; Origasa H;
    J Cardiol; 2015 Mar; 65(3):175-7. PubMed ID: 25169015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.
    Kumagai N; Nusser JA; Inoue H; Okumura K; Yamashita T; Kubo T; Kitaoka H; Origasa H; Atarashi H;
    Am J Cardiol; 2017 Jul; 120(2):230-235. PubMed ID: 28532776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.